Kentucky Recall Lawyer Larry Jones: New Scientific Study Relates Heart Attacks and Avandia Usage
The American Diabetes Association has accepted for publication in its prestigious medical journal, Diabetes Care, a study by Harvard researchers that shows users of the diabetes drug Avandia© have more than double the risk of a heart attack compared to other diabetes drugs. Further, a jointly sponsored study by both GlaxoSmithKline and i3 Drug Safety, an independent drug-safety firm, will appear in the journal Clinical Therapeutics showing that Avandia users have a 35-41% increased risk of a heart attack over users of Actos©, Avandia’s main competitor.
Bahe Cook Cantley & Jones recall lawyer Larry Jones says, "These results show that Avandia's manufacturer have placed Avandia users to an unconscionable increased risk of heart attacks." But this isn't the first indication of the increased risk. In 2007, the Food and Drug Administration required a “Black Box” warning be added to Avandia’s label about the heart risks associated with drug. Yet, the maker failed to remove Avandia from the market.
For more information about the rights of those who have suffered heart attacjs while using Avandia, contact Larry Jones toll free at 1-866-587-0002 or click here to email Larry.
